The Individualized Treatment of Opioid Use Disorder.
J Manag Care Spec Pharm
; 25(6): 634-636, 2019 Jun.
Article
em En
| MEDLINE
| ID: mdl-31134856
ABSTRACT
DISCLOSURES No outside funding supported the writing of this commentary. Boyett is Chief Medical Officer and founder of the medical division of Pathway Healthcare, which provides treatment for opioid and other drug addictions.
Texto completo:
1
Coleções:
01-internacional
Contexto em Saúde:
2_ODS3
/
8_ODS3_consumo_sustancias_psicoactivas
Base de dados:
MEDLINE
Assunto principal:
Transtornos Relacionados ao Uso de Opioides
Limite:
Humans
Idioma:
En
Revista:
J Manag Care Spec Pharm
Ano de publicação:
2019
Tipo de documento:
Article